Opioid Patient-Prescriber Agreement
The Food and Drug Administration (FDA) developed an Opioid Patient-Prescriber Agreement (PPA) as part of its Safe Use Initiative that is available to use and adopt throughout the health care ecosystem.
Current (63)
All Articles (74)
- Articles by date
- November 2024 (1)
- October 2024 (2)
- September 2024 (1)
- August 2024 (1)
- July 2024 (1)
- June 2024 (1)
- March 2024 (3)
- February 2024 (2)
- January 2024 (2)
- December 2023 (3)
- November 2023 (3)
- October 2023 (2)
- September 2023 (3)
- August 2023 (1)
- July 2023 (2)
- June 2023 (1)
- May 2023 (1)
- April 2023 (3)
- March 2023 (2)
- February 2023 (1)
- January 2023 (4)
- December 2022 (2)
- November 2022 (2)
- October 2022 (1)
- September 2022 (2)
- August 2022 (1)
- July 2022 (6)
- June 2022 (1)
- May 2022 (2)
- April 2022 (3)
- March 2022 (1)
- February 2022 (1)
- January 2022 (2)
- November 2021 (3)
- October 2021 (1)
- September 2021 (2)
- August 2021 (1)
- July 2021 (3)
- Categories
- Featured Articles (1)
- GEHA Connection Dental Network News (51)
- GEHA Connection Dental Network Provider Newsletter (21)
- Vendor Outage Notice (1)